Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome

International Journal of Adolescent Medicine and Health

Volumn 17, Issue 2, 2005, Pages 187-188

  Dew, Rachel E ^a   Rosenquist, Peter B ^a   McCall, W Vaughn ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Aripiprazole; Atypical antipsychotics; Neuroleptic Malignant Syndrome; United States

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CREATINE KINASE; DANTROLENE; HALOPERIDOL; OLANZAPINE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; BLOOD PRESSURE; BRAIN DISEASE; BREATHING RATE; CASE REPORT; CATATONIA; COGNITIVE DEFECT; CREATINE KINASE BLOOD LEVEL; DISEASE EXACERBATION; DISEASE SEVERITY; DYSTONIA; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; INCONTINENCE; LABORATORY TEST; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; OPISTHOTONUS; PSYCHOSIS; TACHYCARDIA; TEMPERATURE; TREATMENT OUTCOME; TREMOR;

EID: 21044459333     PISSN: 03340139     EISSN: None     Source Type: Journal    
DOI: 10.1515/IJAMH.2005.17.2.187     Document Type: Article

References (1)

1. Ananth JPS, Gunatilake S, Bugoyne K, et al. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004;65(4):464-70.